Literature DB >> 8547087

Trisomy 3 is a consistent chromosome change in malignant lymphoproliferative disorders preceded by cold agglutinin disease.

L Michaux1, J Dierlamm, I Wlodarska, M Stul, A Bosly, A Delannoy, A Louwagie, C Mecucci, J J Cassiman, H van den Berghe.   

Abstract

Cold-antibody autoimmune haemolytic anaemia is a rare entity that has been associated with a wide variety of pathological processes, including malignant lymphoproliferative disorders. In this retrospective study we recorded, as far as possible, clinical, haematological, immunological, morphological, pathological, cytogenetic and molecular data on 10 patients with cold agglutinin disease (CAD). Cytogenetic anomalies were found in four cases in which an underlying lymphoma could be evidenced. Trisomy 3 was the only recurrent aberration in our series. It was observed in all patients with abnormal karyotype, either as a complete trisomy or as a partial trisomy of the long arm. The importance of this particular karyotypic aberration in the monitoring of CAD is emphasized.

Entities:  

Mesh:

Year:  1995        PMID: 8547087     DOI: 10.1111/j.1365-2141.1995.tb05315.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  4 in total

1.  Cold agglutinin-mediated autoimmune haemolytic anaemia associated with diffuse large B cell lymphoma.

Authors:  Sariya Wongsaengsak; Magdalena Czader; Attaya Suvannasankha
Journal:  BMJ Case Rep       Date:  2018-07-10

2.  Cold agglutinin-associated B-cell lymphoproliferative disease shows highly recurrent gains of chromosome 3 and 12 or 18.

Authors:  Agnieszka Małecka; Jan Delabie; Ingunn Østlie; Anne Tierens; Ulla Randen; Sigbjørn Berentsen; Geir E Tjønnfjord; Gunhild Trøen
Journal:  Blood Adv       Date:  2020-03-24

3.  Occurrence of lymphoplasmacytic lymphoma 6 years after amelioration of primary cold agglutinin disease by rituximab therapy.

Authors:  Hiroaki Tanaka; Shinichiro Hashimoto; Yasumasa Sugita; Shio Sakai; Yusuke Takeda; Daijiro Abe; Toshiyuki Takagi; Chiaki Nakaseko
Journal:  Int J Hematol       Date:  2012-08-11       Impact factor: 2.490

Review 4.  New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia.

Authors:  Sigbjørn Berentsen
Journal:  Front Immunol       Date:  2020-04-07       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.